A peer reviewed article discusses the use of convalescent plasma, i.e. passive polyclonal antibody (Ab) for treatment of COVID-19, as an effective, safe and successful treatment for COVID-19.
The article also outlines a brief methodology for treatment using convalescent plasma drawing upon the experience in France.
In India, Plasma therapy is about to be tested in a clinical trial in Kerala and Karnataka.
Tiberghien, P., de Lambalerie, X., Morel, P., Gallian, P., Lacombe, K. and Yazdanpanah, Y. (2020), Collecting and evaluating convalescent plasma for COVID‐19 treatment: why and how. Vox Sang. Accepted Author Manuscript. doi:10.1111/vox.12926
